Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05952141 · ClinicalTrials.gov registry record · NA
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
A NA study of Cervical Cancer, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 680
- Enrollment target
- 3
- Study locations
NCT05952141 is a NA study of Cervical Cancer that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 680 participants, above the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target (20% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT05952141, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 680 participants
- Enrollment target
- 3
- Study locations
Study Summary
Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design.
Conditions Studied
Interventions
- BEHAVIORAL Clinic Outreach
- BEHAVIORAL Enhanced Outreach
- BEHAVIORAL Low-Touch Strategy
- BEHAVIORAL High-Touch Strategy
Study Locations (3)
Pennsylvania
- University of Pennsylvania - Philadelphia
North-East District
- Nyangabgwe Referral Hospital - Francistown
Other
- Princess Marina Hospital - Gaborone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 680 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05952141
The ClinicalTrials.gov registry entry for NCT05952141 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 680 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target (20% higher). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 4 interventions - of which Clinic Outreach is the first listed.
NCT05952141 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, North-East District, Other.
Frequently Asked Questions
What is clinical trial NCT05952141 about?
NCT05952141 is a clinical study titled "Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana". Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design.
What is the current status of trial NCT05952141?
This trial is currently recruiting. It is a NA study. The enrollment target is 680 participants. The study started on 2023-09-01. Estimated completion is 2027-08-31.
What conditions does trial NCT05952141 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT05952141?
The interventions under investigation include: Clinic Outreach (BEHAVIORAL), Enhanced Outreach (BEHAVIORAL), Low-Touch Strategy (BEHAVIORAL), High-Touch Strategy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05952141?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05952141 being conducted?
This trial has 3 study locations across Pennsylvania, North-East District. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.